Concerto Biosciences Reports Phase 1B Trial Success For ENS-002
28 Oct 2025 //
PR NEWSWIRE
Concerto Biosciences Gets FDA Clearance For Atopic Dermatitis Treatment
26 Jun 2024 //
PR NEWSWIRE
Concerto Biosciences Announces Strategic Business Development Hire
06 Feb 2023 //
BUSINESSWIRE

Market Place
Sourcing Support